Moneycontrol PRO
HomeNewsWorldFlorona: Not a new variant, but a blend of COVID and flu. All that matter explained

Florona: Not a new variant, but a blend of COVID and flu. All that matter explained

As Israel reported its first case of COVID-19 and Influenza co-infection, we bring you the details of what this means

January 03, 2022 / 13:51 IST
Representative image/AFP

Florona is a portmanteau of influenza and Coronavirus. It is not a new virus, nor a variant of the SARS-CoV-2 or COVID-19 virus, but occurs when an individual suffers dual infection (co-infection) from the COVID-19 and influenza (or flu) viruses.

Is it a new development?

No. The World Health Organisation (WHO) has a full page dedicated to explaining that people can be co-infected by the flu and COVID-19 at the same time.

Symptoms include shortness of breath, loss of appetite, confusion, persistent pain or pressure in the chest, and high temperature (above 38°C). According to WHO, those with mild symptoms of co-infection, can be treated at home without the need of hospitalisation.

Then why is it in the news now?

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

Israeli newspaper Yedioth Ahronoth recently reported the country’s first case of Florona in an unvaccinated pregnant woman, who was admitted to the Rabin Medical Centre to give birth.

Why is it significant?

The winter months are known as ‘flu season’ as the weather results in lower immunity against seasonal cold and flu viruses. Vulnerable populations for both the diseases overlap and include the elderly, those pregnant, those immune-compromised (such as HIV and hepatitis patients), those with existing severe medical conditions (diseases of heart, liver and kidney), and healthcare workers.

Both the viruses cause respiratory diseases and have similar symptoms such as cough, fatigue, fever, headache, sore throat and runny nose. The symptoms for both can range from mild to fatal.

Both are also spread in similar ways – through droplets and aerosols when an infected person coughs, sneezes, speaks, sings or breathes, which land in the eyes, nose or mouth of people who are nearby (usually within one metre). Another way of being infected is through touching contaminated surfaces and then touching eyes, nose or mouth without cleaning their hands.

How can you protect yourself?

Preventive measures include social distancing, wearing of mask, frequent hand sanitisation, avoid touching eyes, nose and mouth, avoid crowded and stuffy areas, using tissues to cough or sneeze and immediately disposing it.

The WHO also recommends getting vaccinated. Since the vaccines are different, you will need both the vaccines. The most effective way to prevent hospitalisation and severe COVID-19 and influenza is vaccination with both the jabs, it said.

The influenza vaccine has been safely used since the 1940s for older individuals, young children, pregnant people, people with underlying health conditions, and health workers. In fact, the influenza vaccine is recommended to be taken yearly among high-risk groups.

COVID-19 vaccines are being safely administered across countries to those above 18 years of age. They include people with co-morbidities and chronic but stable conditions. Those with the history of severe allergies to vaccines or vaccine ingredients and compromised immune system will have to consult their doctors before taking the COVID-19 vaccination.

If infected, what is the treatment?

As per the WHO, treatments for COVID-19 and influenza are different.

The treatment options in use for COVID-19 at medical facilities include oxygen, corticosteroids, and IL6 receptor blockers for severely ill patients. Treatment for people with severe respiratory illness includes advanced respiratory support such as the use of ventilators. Several other treatment options for COVID-19 are currently in clinical trials.

Antiviral drugs for influenza can reduce severe complications and death, and they are especially important for high-risk groups. It’s important to remember that antibiotics are not effective against influenza or COVID-19 viruses.

Jocelyn Fernandes
first published: Jan 3, 2022 01:41 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Subscribe to Tech Newsletters

  • On Saturdays

    Find the best of Al News in one place, specially curated for you every weekend.

  • Daily-Weekdays

    Stay on top of the latest tech trends and biggest startup news.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347
CloseGen AI Masterclass